Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Corticosteroids in Hyperinflammatory Phenotype of Critical Illness Trial sites expanded: 1 → 11 locations Bin DuPhase 2 NCT07511582
  2. Minor: BEACON-AA · Apixaban With or Without Clopidogrel in Stroke · Atrial Fibrillation and Cerebral Atherosclerosis Trial sites expanded: 0 → 21 locations Yonsei UniversityPhase 4 NCT07237308
  3. Minor: Progressive Supranuclear Palsy Clinical Trial Platform Trial sites expanded: 21 → 24 locations Adam BoxerPhase 2 NCT07173803
  4. Minor: Effective and Safe Odronextamab is Compared to Standard of Care · Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma Study completion moved earlier from May 29, 2029 to May 29, 2028 Regeneron PharmaceuticalsPhase 3 NCT06230224
  5. Minor: Guselkumab Subcutaneous Therapy · Moderately to Severely Active Crohn's Disease Study completion moved earlier from Oct 30, 2028 to Mar 27, 2028 Janssen Research & Development, LLCPhase 3 NCT05197049
  6. Minor: ORJ-001 · IPF Start date pushed from Oct 2026 to Nov 2026 Oorja Bio, Inc.Phase 2 NCT07869147
  7. Minor: SPY072 · Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial) Start date changed from estimate of Sep 2026 to Oct 6, 2026 Spyre Therapeutics, Inc.Phase 2 NCT07766005
  8. Minor: National Registry of Noonan Syndrome Trial sites reduced: 35 → 13 locations Istituto Giannina GasliniNot specified NCT07881159
  9. Minor: Food Effect of UBT48128 Tablets in Healthy Participants Study completion pushed from Dec 30, 2026 to Mar 31, 2027 The United Bio-Technology (Hengqin) Co., Ltd.Phase 1 NCT07922798
  10. Minor: Dietary Supplement Effect on Improvement of Hair Condition · Occasional Hair Loss Start date pushed from Oct 2026 to Nov 2026 Lacer S.A.Not applicable NCT07835646
  11. Minor: Methoxyamine, Cisplatin, and Pemetrexed Disodium · Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin Study completion pushed from Oct 15, 2026 to Oct 15, 2027 National Cancer Institute (NCI)Phase 1/2 NCT02535312
  12. Minor: Radiation Therapy With or Without Chemotherapy · High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery Study completion moved earlier from Dec 31, 2031 to Sep 30, 2031 Radiation Therapy Oncology GroupPhase 2 NCT01220583
  13. Minor: GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial Final enrollment: 33 participants (planned 30) Vanderbilt University Medical CenterPhase 2/3 NCT06162715
  14. Minor: Adding IL-2 to Tebentafusp to Eradicate Cancer Progression Study completion pushed from Sep 2027 to Sep 1, 2028 St Vincent's Hospital, SydneyPhase 1/2 NCT07063875
  15. Minor: MVA-BN · HIV for the Prevention of Mpox Infection, in Kinshasa, DRC Study completion pushed from Nov 30, 2026 to Dec 31, 2026 Institute of Tropical Medicine, BelgiumPhase 2 NCT06839989
  16. Minor: Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction Study completion pushed from Oct 30, 2026 to Dec 30, 2026 Xijing HospitalPhase 2 NCT06576921
  17. Minor: Natalizumab · ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy Start date changed from estimate of Nov 1, 2026 to Nov 10, 2026 University of Michigan Rogel Cancer CenterPhase 2 NCT07892027
  18. Minor: Impact of AHCC® Supplementation · Respiratory Tract Infections Among Children Age 4-6 Years Old Interventions modified Hasanuddin UniversityPhase 4 NCT07479394
  19. Minor: Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response Primary completion date changed from estimate of Jun 2026 to Oct 30, 2026 University of ZurichNot specified NCT06822491
  20. Minor: Skin Changes From the Use of Moisturizers · Cancer Experiencing Dermatological Adverse Events Start date pushed from Oct 2026 to Nov 2026 Stanford UniversityNot applicable NCT07767448
  21. Minor: Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception Study completion pushed from Sep 30, 2026 to Dec 31, 2026 Brigham and Women's HospitalNot applicable NCT03882073
  22. Minor: Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders Study completion pushed from Dec 2026 to May 2027 St. Jude Children's Research HospitalNot specified NCT04416178
  23. Minor: Sports Based Structured Cognitive Therapy Program on Attention, Memory and Behavior for School Going Children Study completion pushed from Oct 30, 2026 to Jan 30, 2027 Riphah International UniversityNot applicable NCT07786532
  24. Minor: Performance, Shade Matching, and Patient Satisfaction of Different Resin Composite Layering Techniques Using 3D Printed Cast Study completion moved earlier from Dec 27, 2026 to Nov 20, 2026 Al-Azhar UniversityNot applicable NCT07813949
  25. Minor: Use of Respiratory Quotient ''RQ'' Improve Treatment Outcomes for Intensive Care Unit (ICU) Patients? Study completion pushed from Oct 31, 2027 to Dec 31, 2027 Poznan University of Medical SciencesNot applicable NCT07457554